Consistent with these findings, the current study confirmed that the semaglutide-intensified treatment group exhibited reduced fasting plasma glucose, fasting insulin, total cholesterol, triglyceride, and LDL-C levels compared with baseline
Long term data is needed to determine the efficacy of these combinations compared to GLP-1 receptor agonists
Nevertheless, translating these laboratory findings to clinical joint pain relief in humans requires further investigation
But the authors of those studies told Politico that their work had been misinterpreted
Final Thoughts Ozempic offers benefits for blood pressure management alongside its primary role in type 2 diabetes treatment
By the end of the trial, 23 of the 102 participants assigned to treatment dropped out of the study (compared to only 15 dropouts on placebo.) Many taking the drug complained of nausea, one of the most common side effects of GLP-1 drugs, which work to regulate blood sugar, and end up slowing down digestion